DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stake Boosted by Sound Income Strategies LLC

Sound Income Strategies LLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 43.7% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 347,841 shares of the medical instruments supplier's stock after buying an additional 105,777 shares during the quarter. Sound Income Strategies LLC owned approximately 0.17% of DENTSPLY SIRONA worth $5,197,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of XRAY. Treasurer of the State of North Carolina lifted its holdings in DENTSPLY SIRONA by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after acquiring an additional 560 shares during the last quarter. Quarry LP lifted its holdings in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares during the last quarter. Federated Hermes Inc. boosted its position in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after purchasing an additional 915 shares during the period. Covestor Ltd grew its stake in DENTSPLY SIRONA by 14.9% during the 4th quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier's stock worth $158,000 after buying an additional 1,081 shares during the last quarter. Finally, Colonial Trust Co SC acquired a new stake in DENTSPLY SIRONA in the fourth quarter worth $26,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

XRAY stock traded up $0.03 during trading hours on Wednesday, hitting $15.40. 1,669,361 shares of the stock traded hands, compared to its average volume of 2,962,807. The stock has a 50-day simple moving average of $14.95 and a 200 day simple moving average of $16.78. The company has a market cap of $3.07 billion, a P/E ratio of -3.39, a P/E/G ratio of 1.14 and a beta of 0.95. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.95. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same quarter last year, the firm posted $0.42 EPS. The business's revenue for the quarter was down 7.8% on a year-over-year basis. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.16%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several analyst reports. Mizuho reduced their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Piper Sandler reduced their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Finally, Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.